Ruxolitinib, 25 mg

Ruxolitinib is a JAK inhibitor of JAK1 JAK2 and JAK3. JAKs or Janus-associated kinases are tyrosine kinases found in the cytoplasm that are known to active the signaling of certain growth factor receptors and cytokines.